![Steve Westing](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Steve Westing has been Vice President of Medical and Scientific Development for OccuLogix, Inc. since April 10, 2006.
Previously, he was Associate Director-Advisory and Thought Leader Services and a Member of the Ophthalmology Commercial Strategy Team for Genentech, Inc. Prior to joining Genentech in May 1996, Dr. Westing worked at Loredan Biomedical, Inc. since May 1990.
He received a PhD in Muscle Physiology from The Karolinska Institute, Stockholm, Sweden.
Eerdere bekende functies van Steve Westing
| Bedrijven | Functie | Einde |
|---|---|---|
| TEARLAB CORPORATION | Hoofd Techniek/Wetenschap/O&O | 09-01-2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Opleiding van Steve Westing
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
TearLab Corp., Inc.
 TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
